---
category: news
title: "Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences' i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph ..."
excerpt: "Castle presented new data on the integration of the DecisionDxÂ®-Melanoma test with clinicopathologic features (i31-GEP)."
publishedDateTime: 2021-04-15T11:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20210415005322/en/Late-Breaking-New-Independent-Validation-Study-of-1674-Patients-Demonstrates-Castle-Biosciences-i31-GEP-Artificial-Intelligence-Algorithm-Improves-Precision-of-Sentinel-Lymph-Node-Positivity-Prediction-in-Cutaneous-Melanoma"
webUrl: "https://www.businesswire.com/news/home/20210415005322/en/Late-Breaking-New-Independent-Validation-Study-of-1674-Patients-Demonstrates-Castle-Biosciences-i31-GEP-Artificial-Intelligence-Algorithm-Improves-Precision-of-Sentinel-Lymph-Node-Positivity-Prediction-in-Cutaneous-Melanoma"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - Machine Learning
  - AI

secured: "NBkecbpiznzMJoT3hf+tQ7b0/fWg0WjnybVfCG49fX06Hr4fCVBjnzO4u0nbBMnPL+ePGiI8ML6ZghkxmzqckCgMSdbCyWFirBL54Ekrs6ggyofLYv0i+XR5STaTBsk5vQwCxEXiSwvxTs7yfv5AC/3IGVqrc4Smk5vrhYi+bsAiIU1BRitIB5FKZCeZs7Tk233iMfwqRoDOTnLK3inWDmDL9/wx8u80coW6J/c23nEjOKyKC9GpQY9yx37QB7EQXZ4Y8kUe8nqRq1++fA017fFuoYTXiecDwhayurimh0/Nn+gGZaiZuCIDRJeB/md9312bW1cZHG5d61/wTcnN5Fz6lkqwydDOE10WxzIF55w=;ZB8ZEsa03J5PY274J+TReQ=="
---

